Contact Us Youtube Facebook linkedin Twitter

Abbott Case Study Competition

You are invited to submit case studies that address contemporary issues in the practice of diabetes care, diabetes education and self-management involving the use of flash glucose monitoring with or without ambulatory glucose profile.

This program is financially supported by Abbott Diabetes Care.

Click here to submit your case study Click here to get to the consent form for participants
Click here to download sample application Click here to download sample consent form


Entries can be submitted either in writing or verbally as a video.

Written case study

Maximum 600 words

Submissions to be sent via SurveyMonkey

Video case study

Maximum 6 minutes

Video to be uploaded on YouTube then provide link in the application form via SurveyMonkey

Topics for case study submissions

A submitted case study must include principles of person-centred care (see Appendix) while discussing the use of flash glucose monitoring1 with or without ambulatory glucose profile2.

Please address any (one or many) of the following questions in your submitted case study:

  1. How have the patient’s outcomes (clinical or non-clinical) improved with this technology?
  2. How has the technology been used to make a difference to a patient’s quality of life?
  3. How has the technology changed practice for an individual health professional or the diabetes care team?
  4. How has it helped to prevent an adverse event?
  5. Describe any challenges patients have found with this technology. What has been done as a consequence?


  1. The flash glucose monitoring system utilises a glucose sensor/transmitter and hand held receiver to measure multiple glucose data points from interstitial fluid. The glucose sensor is worn on the arm continuously for 14 days and includes a transmitter to communicate with the hand held glucose device. The hand held glucose receiver is used to manually transfer the data, and displays the current glucose level, trend arrow and history of the past 8 hours without the need for capillary glucose testing. The receiver may also be used with capillary blood as an insulin dose advisor, however calibration with capillary blood is not required.
  2. The ambulatory glucose profile is a software approach to collating and analysing glucose data. It combines glucose readings from multiple days/weeks of glucose monitoring into a single 24 hour period, featuring statistical information such as average, interquartile and interdecile ranges.

Selection process

Round 1

Selected by reviewing panel

  1. Reviewers to select top 10 winning case studies (5 from each format)
    1. 5 winning written case studies will be published in print (more details TBC)
    2. 5 winning video case studies will be available via YouTube
  2. Among these 10, top 4 (2 of each format) to be invited to round 2

Round 2

Selected by delegates at the ADS-ADEA Annual Scientific Meeting for the People’s Choice Award

  1. Top 4 (2 of each format) will be invited to present and discuss their case studies orally at the 2017 ADS-ADEA Annual Scientific Meeting (ASM) (10 minute presentation + 2 minute Q&A)
  2. Delegates to vote for their favourite presentation to find recipient for the People’s Choice Award
  3. Recipient of People’s Choice Award to be announced at the ADEA Award Ceremony after the Annual General Meeting at the ASM on Friday 1 September 2017

Important dates

Prize structure

Top 10

People’s Choice Award

The ultimate award title acknowledging the best case study in the whole competition, selected by delegates at the ASM after the oral presentation and Q&A of the submitted case studies. Only the top 4 are eligible to be considered for this award.

Reviewing panel

  1. Jenny Carmuciano, Person with type 1 diabetes
  2. Toni Eatts, Editor of Diabetic Living
  3. Dr Sue-Lynn Lau, Endocrinologist at Westmead Hospital
  4. Dr Kate Marsh, Editor of the Australian Diabetes Educator publication
  5. Peta Tauchmann, Chair of the ADEA Clinical Practice Committee

Consent process

Applicants must obtain consent of people with diabetes discussed in the submitted case studies, giving permission that they are happy for the selected case studies to be published via print and/or online by ADEA. 

Terms and conditions

  1. Submitted case studies must include any principle(s) of person-centred care while discussing one of the four identified issues.
  2. Both written and video case studies must be completed via SurveyMonkey by 9am 18 April 2017.
    1. Written case study can be provided as text in SurveyMonkey.
    2. Video case study should be uploaded to YouTube or Vimeo with URL provided in SurveyMonkey.
  3. Parts of the submitted case studies that are over the limit (i.e. from the 601st word of written case study, or from the 7th minute of video case study) will not be considered.
  4. Submitted case studies must de-identify details of the person in the case study to ensure confidentiality. This means neither names nor initials, locations mentioned in the submissions, e.g. ‘a 32-year-old woman with newly diagnosed type 1 diabetes attended our health service for …’.
  5. Applicants must obtain consent of people with diabetes discussed in the submitted case studies, giving permission that they are happy for the selected case studies to be published via print and/or online by ADEA. Submitted case study without a matching consent will not be reviewed.
  6. Submitted case studies must follow Vancouver referencing style.
  7. 10 successful applicants will receive registrations to the 2017 ASM, financially supported by Abbott Diabetes Care.
  8. 10 successful case studies will be displayed at the Abbott Diabetes Care exhibition stand during the ASM.
  9. Recipient of the People’s Choice Award might have their case study published in ADE November.
  10. Members of the Reviewing Panel and members of the Abbott Libre Advisory Committee are not eligible for this competition.
  11. If no video submission is received, the Reviewing Panel will make decision on the top 10 successful applicants.

Principles of person-centred care

Health Care

  1. I focus on the person and their goals and overall wellbeing.
  2. I’m respectful of the person’s culture and health beliefs.
  3. I respect the person’s decisions about their health care and include carers and family members (with the person’s consent).
  4. I proactively outline care options and known health benefits, risks, access and costs.
  5. I check each person has understood, agrees with and can action their self-managed care.
  6. I review outcomes and use the person’s experiences, needs, preferences and values as the basis for planning the next period of self-management and professional care.
  7. I communicate with the person’s other health providers to facilitate holistic care (with the person’s consent).
  8. I partner with the person so they can communicate with key people in their life to support environments that are non-discriminatory, safe and supportive.

Policy and System Improvement

  1. I partner with consumers and consumer representatives to educate colleagues and the wider community about, and advocate for, supportive and inclusive environments for people living with diabetes.
  2. I partner with consumers and consumer representatives in policy and service development and ongoing quality assurance.